- ￥600 - 900
- MedChemExpress(MCE)
- 美国
- HY-B0405
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
38396-39-3
- 规格：
10 mM * 1 mL/100 mg/500 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥660.0 |
|---|---|---|---|
| 规格： | 100 mg | 产品价格： | ￥600.0 |
| 规格： | 500 mg | 产品价格： | ￥900.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Bupivacaine
CAS No. : 38396-39-3
MCE 国际站：Bupivacaine
产品活性：Bupivacaine 是一种 NMDA 受体抑制剂。Bupivacaine 可以阻断钠、L-钙和钾通道。Bupivacaine 有效阻断 SCN5A 通道，IC50 为 69.5 μM。Bupivacaine 可用于慢性疼痛的研究。
研究领域：Membrane Transporter/Ion Channel | Neuronal Signaling
作用靶点：iGluR | Sodium Channel | Calcium Channel | Potassium Channel
In Vitro: Bupivacaine inhibits NMDA receptor-mediated synaptic transmission in the dorsal horn of the spinal cord, an area critically involved in central sensitization.
Bupivacaine influences the voltage dependency of channel activation and steady-state inactivation by shifting the membrane potential of half-maximal activation/inactivation toward somewhat more negative membrane potentials. In their inactivated state, SCN5A channels are slightly sensitive toward Bupivacaine IC50=2.18±0.16 μM.
Bupivacaine reversibly inhibits the SK2 channel in a dose-dependent manner with the IC 50 of 16.5 μM.
相关产品：Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Membrane Transporter/Ion Channel Compound Library | Neuronal Signaling Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Antiviral Compound Library | Drug Repurposing Compound Library | NMPA-Approved Drug Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Anti-Alzheimer's Disease Compound Library | Neuroprotective Compound Library | Drug-Induced Liver Injury (DILI) Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Parkinson's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Rare Diseases Drug Library | Children’s Drug Library | Antidepressant Compound Library | EMA-Approved Drug Library | Calcium Channel Blocker Library | Sodium Channel Blocker Library | Potassium Channel Compound Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Anti-Prostate Cancer Compound Library | Non-steroidal Anti-Inflammatory Compound Library | Heterocyclic Compound Library | Off-patent Drug Library | Antihypertensive Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Mitochondrial Toxicity Compound Library | Ion Channel Compound Library | Nigericin sodium salt | Thapsigargin | Ionomycin | L-Ascorbic acid | Yoda 1 | BAPTA-AM | Corticosterone | Minocycline hydrochloride | Verapamil | 2-Aminoethyl diphenylborinate | Branaplam | Acetylcholine chloride | D-AP5 | Amiloride hydrochloride | Dizocilpine maleate | GSK1016790A | NMDA | L-Glutamic acid | Nifedipine | Fasudil Hydrochloride | Ebselen | Evans Blue | Rosuvastatin Calcium | CNQX | SCH-23390 hydrochloride | Kynurenic acid | Halofuginone | Glibenclamide
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验) Lidocaine‐bupivacaine mixture (see recipe ) Dissecting scissors, sterile
62 99 2.6 0.13 0.8 布比卡因 bupivacaine - 2 95 7.1 0.9 2.4 咖啡因 caffeine 100
布美他尼bumetanide 81 62 99 2.6 0.13 0.8 布比卡因bupivacaine - 2 95 7.1 0.9 2.4 咖啡因caffeine 100 1.1 36
技术资料暂无技术资料 索取技术资料
